Rothschild Investment LLC’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$758K Buy
5,436
+63
+1% +$8.82K 0.04% 318
2025
Q4
$660K Sell
5,373
-7
-0.1% -$851 0.04% 310
2025
Q3
$597K Buy
5,380
+841
+19% +$95.6K 0.03% 314
2025
Q2
$503K Buy
4,539
+84
+2% +$8.94K 0.03% 337
2025
Q1
$499K Sell
4,455
-8
-0.2% -$825 0.03% 333
2024
Q4
$412K Buy
4,463
+303
+7% +$27.3K 0.03% 378
2024
Q3
$349K Sell
4,160
-1,427
-26% -$109K 0.02% 405
2024
Q2
$383K Buy
5,587
+925
+20% +$61.7K 0.03% 382
2024
Q1
$341K Sell
4,662
-425
-8% -$32.7K 0.02% 378
2023
Q4
$412K Buy
5,087
+640
+14% +$49.8K 0.03% 308
2023
Q3
$333K Sell
4,447
-176
-4% -$13.5K 0.03% 366
2023
Q2
$356K Buy
4,623
+288
+7% +$23K 0.03% 352
2023
Q1
$360K Hold
4,335
0.03% 344
2022
Q4
$372K Sell
4,335
-1,150
-21% -$91.1K 0.03% 333
2022
Q3
$338K Hold
5,485
0.03% 336
2022
Q2
$339K Hold
5,485
0.03% 355
2022
Q1
$326K Sell
5,485
-219
-4% -$14K 0.03% 381
2021
Q4
$414K Sell
5,704
-150
-3% -$10.3K 0.03% 353
2021
Q3
$409K Hold
5,854
0.03% 344
2021
Q2
$403K Buy
5,854
+747
+15% +$49.9K 0.03% 354
2021
Q1
$330K Buy
5,107
+97
+2% +$6.25K 0.03% 372
2020
Q4
$292K Sell
5,010
-2,951
-37% -$178K 0.03% 360
2020
Q3
$503K Hold
7,961
0.05% 260
2020
Q2
$613K Buy
7,961
+2,126
+36% +$163K 0.07% 219
2020
Q1
$436K Sell
5,835
-820
-12% -$56.7K 0.06% 260
2019
Q4
$432K Hold
6,655
0.04% 311
2019
Q3
$422K Sell
6,655
-300
-4% -$19.6K 0.05% 265
2019
Q2
$470K Sell
6,955
-500
-7% -$32.9K 0.06% 264
2019
Q1
$485K Sell
7,455
-4,550
-38% -$302K 0.06% 256
2018
Q4
$751K Sell
12,005
-980
-8% -$68.5K 0.1% 182
2018
Q3
$1M Sell
12,985
-1,395
-10% -$105K 0.12% 162
2018
Q2
$1.02M Sell
14,380
-75
-0.5% -$5.3K 0.13% 160
2018
Q1
$1.09M Buy
14,455
+185
+1% +$14.7K 0.14% 157
2017
Q4
$1.02M Sell
14,270
-5,084
-26% -$386K 0.11% 191
2017
Q3
$1.57M Sell
19,354
-14,535
-43% -$1.11M 0.18% 140
2017
Q2
$2.4M Sell
33,889
-7,320
-18% -$487K 0.27% 92
2017
Q1
$2.8M Buy
41,209
+6,600
+19% +$464K 0.33% 76
2016
Q4
$2.48M Sell
34,609
-2,580
-7% -$192K 0.3% 86
2016
Q3
$2.94M Buy
37,189
+7,385
+25% +$600K 0.36% 79
2016
Q2
$2.49M Buy
29,804
+4,450
+18% +$395K 0.32% 85
2016
Q1
$2.33M Sell
25,354
-5,855
-19% -$528K 0.3% 90
2015
Q4
$3.16M Buy
31,209
+385
+1% +$40.1K 0.4% 68
2015
Q3
$3.03M Buy
30,824
+5,410
+21% +$601K 0.4% 67
2015
Q2
$2.98M Buy
25,414
+13,130
+107% +$1.43M 0.35% 73
2015
Q1
$1.21M Buy
12,284
+2,823
+30% +$287K 0.14% 161
2014
Q4
$892K Buy
9,461
+3,979
+73% +$412K 0.11% 201
2014
Q3
$584K Buy
5,482
+34
+0.6% +$3.33K 0.07% 270
2014
Q2
$452K Buy
5,448
+92
+2% +$7.16K 0.06% 284
2014
Q1
$380K Buy
5,356
+920
+21% +$72.2K 0.05% 310
2013
Q4
$333K Buy
+4,436
New +$309K 0.05% 323

Other funds holding GILD

Rothschild Investment LLC's GILD Position: Q1 2026 in Review

Rothschild Investment LLC increased its Gilead Sciences (GILD) stake by 1.2% in Q1 2026, buying an estimated $8.82K and bringing the position to 5,436 shares worth $758K. The position accounts for 0.04% of the portfolio, ranked #318.

Rothschild Investment LLC first reported a position in GILD in Q4 2013 and has held it in 50 quarters since. The position peaked at $3.16M in Q4 2015. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Rothschild Investment LLC held 5,436 shares of Gilead Sciences worth $758K as of Q1 2026.
  • Rothschild Investment LLC bought 63 Gilead Sciences shares in Q1 2026, an estimated $8.82K.
  • Gilead Sciences made up 0.04% of Rothschild Investment LLC's portfolio in Q1 2026, its #318 holding.
  • Rothschild Investment LLC first reported a position in Gilead Sciences in Q4 2013 and has held it in 50 quarters since.
  • Rothschild Investment LLC's Gilead Sciences position peaked at $3.16M in Q4 2015.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Rothschild Investment LLC's 13F filing for Q1 2026, filed 7 May 2026.